753 InhibigenTM administration promotes aberrant T cell responses in cancer but may be beneficial for amelioration of autoimmune disease by DeVault, Victoria, Starobinets, Hanna, Arnold, Julie, Rinaldi, Stephanie, Hubbard, Charley, Odeh, Osaruese, Nguyen, Cindy, Apolloni, Laura, Lineker, Dimitry, Flechtner, Jessica, Lam, Hubert

Request full text

Abstract 1762: InhibigensTM subvert otherwise-efficacious cancer vaccines and immunotherapies in conjunction with alterations in the tumor microenvironment by Starobinets, Hanna, Devault, Victoria L., Rinaldi, Stephanie, Arnold, Julie, Odeh, Osaruese, Nguyen, Cindy, Flechtner, Jessica B., Lam, Hubert

Get full text

Inhibigens™ drive pro-tumor responses and may act through non-classical inhibitory mechanisms by DeVault, Victoria L, Starobinets, Hanna, Arnold, Julie, Rinaldi, Stephanie, Odeh, Osaruese, Nguyen, Cindy, Flechtner, Jessica B, Lam, Hubert

Get full text

526 InhibigenTM-specific responses suppress anti-tumor immunity and promote tumor growth by DeVault, Victoria, Dadali, Tulin, Starobinets, Hanna, Lema, Kevin, Rinaldi, Stephanie, Odeh, Osaruese, Arnold, Julie, Sheehan, Dylan, Nguyen, Cindy, Dowal, Louisa, Flechtner, Jessica, Visintin, Alberto, Lam, Hubert

Get full text